Sec Form 4 Filing - Shell William @ Targeted Medical Pharma, Inc. - 2013-09-11

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Shell William 2. Issuer Name and Ticker or Trading Symbol Targeted Medical Pharma, Inc. [ TRGM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO & Chief Scientific Officer (Last) (First) (Middle) C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301 3. Date of Earliest Transaction (MM/DD/YY) 09/11/2013 (Street) LOS ANGELES, CA90077 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $.001 par value per share 09/13/2013 S 2,000 D $ 0.84 ( 5 ) 208,000 I By wife Common Stock, $.001 par value per share 09/11/2013 W 5,303,795 A $ 0 5,370,054 I By trust ( 1 ) Common Stock, $.001 par value per share 09/11/2013 W 300,000 A $ 0 720,799 I By trust ( 2 ) Common Stock, $.001 par value per share 09/11/2013 W 3,422,748 A $ 0 3,422,748 I By trust ( 3 ) Common Stock, $.001 par value per share 09/11/2013 W 8,342,748 D $ 0 722,485 I By trust ( 4 ) Common Stock, $.001 par value per share 09/11/2013 W 99,000 D $ 0 0 D Common Stock, $.001 par value per share 09/11/2013 W 584,795 D $ 0 66,259 I By trust ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Shell William C/O TARGETED MEDICAL PHARMA, INC. 2980 BEVERLY GLEN CIRCLE, SUITE 301 LOS ANGELES, CA90077 X X CEO & Chief Scientific Officer Elizabeth Charuvastra & William Shell Family Trust 3048 NICADA DRIVE LOS ANGELES, CA90077 X William Shell Survivor's Trust 3048 NICADA DRIVE LOS ANGELES, CA90077 X Elizabeth Charuvastra Marital Trust 3048 NICADA DRIVE LOS ANGELES, CA90077 X Signatures /s/ William E. Shell 09/17/2013 Signature of Reporting Person Date Elizabeth Charuvastra and William Shell Family Trust dated 9/26/2008,by /s/ William E. Shell, Trustee 09/17/2013 Signature of Reporting Person Date William Shell Survivor's Trust, by /s/ William E. Shell 09/17/2013 Signature of Reporting Person Date Elizabeth Charuvastra Marital Trust, by /s/ William E. Shell 09/17/2013 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Common stock and warrants are held by William Shell Survivor's Trust. ( 2 )Common stock held by Elizabeth Charuvastra Exemption Trust. William E. Shell is filing on behalf of the Elizabeth Charuvastra Exemption Trust and disclaims any and all pecuniary interest in the Elizabeth Charuvastra Exemption Trust. ( 3 )Common stock held by Elizabeth Charuvastra Marital Trust ( 4 )Common stock held by Elizabeth Charuvastra & William Shell Family Trust. Includes 216,408 shares of common stock beneficially owned by family and friends of Dr. Shell over which the Elizabeth Charuvastra and William Shell Family Trust dated July 27, 2006 and Amended September 29, 2006 maintains voting and dispositive control. ( 5 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.90 per share.

Remarks: As a result of the transactions described in this Form 4, the Elizabeth Charuvastra & William Shell Family Trust is no longer a 10% Owner and is therefore no longer subject to Section 16.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.